Suppr超能文献

PKG1 修饰的 TSC2 调节 mTORC1 活性以对抗心脏不良应激。

PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.

机构信息

Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.

Department of Pharmacology and Molecular Sciences, Johns Hopkins University, Baltimore, MD, USA.

出版信息

Nature. 2019 Feb;566(7743):264-269. doi: 10.1038/s41586-019-0895-y. Epub 2019 Jan 30.

Abstract

The mechanistic target of rapamycin complex-1 (mTORC1) coordinates regulation of growth, metabolism, protein synthesis and autophagy. Its hyperactivation contributes to disease in numerous organs, including the heart, although broad inhibition of mTORC1 risks interference with its homeostatic roles. Tuberin (TSC2) is a GTPase-activating protein and prominent intrinsic regulator of mTORC1 that acts through modulation of RHEB (Ras homologue enriched in brain). TSC2 constitutively inhibits mTORC1; however, this activity is modified by phosphorylation from multiple signalling kinases that in turn inhibits (AMPK and GSK-3β) or stimulates (AKT, ERK and RSK-1) mTORC1 activity. Each kinase requires engagement of multiple serines, impeding analysis of their role in vivo. Here we show that phosphorylation or gain- or loss-of-function mutations at either of two adjacent serine residues in TSC2 (S1365 and S1366 in mice; S1364 and S1365 in humans) can bidirectionally control mTORC1 activity stimulated by growth factors or haemodynamic stress, and consequently modulate cell growth and autophagy. However, basal mTORC1 activity remains unchanged. In the heart, or in isolated cardiomyocytes or fibroblasts, protein kinase G1 (PKG1) phosphorylates these TSC2 sites. PKG1 is a primary effector of nitric oxide and natriuretic peptide signalling, and protects against heart disease. Suppression of hypertrophy and stimulation of autophagy in cardiomyocytes by PKG1 requires TSC2 phosphorylation. Homozygous knock-in mice that express a phosphorylation-silencing mutation in TSC2 (TSC2(S1365A)) develop worse heart disease and have higher mortality after sustained pressure overload of the heart, owing to mTORC1 hyperactivity that cannot be rescued by PKG1 stimulation. However, cardiac disease is reduced and survival of heterozygote Tsc2 knock-in mice subjected to the same stress is improved by PKG1 activation or expression of a phosphorylation-mimicking mutation (TSC2(S1365E)). Resting mTORC1 activity is not altered in either knock-in model. Therefore, TSC2 phosphorylation is both required and sufficient for PKG1-mediated cardiac protection against pressure overload. The serine residues identified here provide a genetic tool for bidirectional regulation of the amplitude of stress-stimulated mTORC1 activity.

摘要

雷帕霉素靶蛋白复合体 1(mTORC1)协调生长、代谢、蛋白质合成和自噬的调节。其过度激活导致包括心脏在内的许多器官的疾病,尽管广泛抑制 mTORC1 有干扰其体内平衡作用的风险。结节性硬化复合物 2(TSC2)是一种 GTP 酶激活蛋白,是 mTORC1 的主要内在调节剂,通过调节 RAS 同源物富集在脑中(RHEB)起作用。TSC2 持续抑制 mTORC1;然而,这种活性被来自多个信号激酶的磷酸化修饰,这些激酶反过来抑制(AMPK 和 GSK-3β)或刺激(AKT、ERK 和 RSK-1)mTORC1 活性。每种激酶都需要多个丝氨酸的参与,这阻碍了其在体内的作用分析。在这里,我们表明,在 TSC2 中的两个相邻丝氨酸残基(小鼠中的 S1365 和 S1366;人类中的 S1364 和 S1365)中的任一个上的磷酸化或获得或丧失功能的突变可以双向控制由生长因子或血流动力学应激刺激的 mTORC1 活性,从而调节细胞生长和自噬。然而,基础 mTORC1 活性保持不变。在心脏中,或在分离的心肌细胞或成纤维细胞中,蛋白激酶 G1(PKG1)磷酸化这些 TSC2 位点。PKG1 是一氧化氮和利钠肽信号的主要效应物,可预防心脏病。PKG1 通过 TSC2 磷酸化抑制心肌细胞肥大和刺激自噬。在持续的心脏压力超负荷后,表达 TSC2 中磷酸化沉默突变(TSC2(S1365A))的纯合敲入小鼠会发展出更严重的心脏病,死亡率更高,这是由于 mTORC1 过度活跃,而 PKG1 刺激无法挽救。然而,通过 PKG1 激活或表达磷酸化模拟突变(TSC2(S1365E)),可减轻杂合子 Tsc2 敲入小鼠的心脏疾病,并提高其对相同应激的存活率。在两种敲入模型中,静息 mTORC1 活性都没有改变。因此,TSC2 磷酸化是 PKG1 介导的心脏对压力超负荷保护所必需和充分的。这里鉴定的丝氨酸残基为双向调节应激刺激的 mTORC1 活性幅度提供了遗传工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbfa/6426636/ed2f983f3292/nihms-1516721-f0005.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验